Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Therapy for obesity based on gastrointestinal hormones

    Bagger, J. I., Christensen, M., Knop, Filip Krag & Vilsbøll, Tina, 2011, In: Review of Diabetic Studies. 8, 3, p. 339-47 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Transforming Motivation for Exercise in a Safe and Kind Environment—A Qualitative Study of Experiences among Individuals with Type 2 Diabetes

    Nielsen, S. G., Danielsen, J. H., Grønbæk, H. N., Mølsted, Stig, Jacobsen, S. S., Vilsbøll, Tina & Varming, A. R., 2022, In: International Journal of Environmental Research and Public Health. 19, 10, 12 p., 6091.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes

    Mehta, R., Billings, L. K., Liebl, A. & Vilsbøll, Tina, 2022, In: Diabetic Medicine. 39, 9, e14901.

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

    Hansen, K. B., Knop, Filip Krag, Holst, Jens Juul & Vilsbøll, Tina, 2009, In: International Journal of Clinical Practice. 63, 8, p. 1154-60 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Trends in One-Year Outcomes of Dialysis-Requiring Acute Kidney Injury in Denmark 2005-2012: A Population-Based Nationwide Study

    Carlson, N., Hommel, K., Olesen, J. B., Soja, A., Vilsbøll, Tina, Kamper, A., Torp-Pedersen, C. & Gislason, Gunnar Hilmar, 2016, In: PLOS ONE. 11, 7, p. 1-14 14 p., e0159944.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Tværsektorielt samarbejde ved behandling af patienter med type 2-diabetes

    Munch, L., Røder, M. E., Rasmussen, I. H., Middelfart, H., Kaarsberg, N., Bennich, B., Knop, Filip Krag & Vilsbøll, Tina, 2018, In: Ugeskrift for Laeger. 180, 8, p. 690-693

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial

    Aaboe, K., Knop, F. K., Vilsbøll, Tina, Deacon, Carolyn F., Holst, Jens Juul, Madsbad, Sten & Krarup, T., 2009, In: Diabetologia. p. 748

    Research output: Contribution to journalConference abstract in journalResearch

  8. Published

    Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose- and non-glucose-induced insulin secretion in patients with type 2 diabetes mellitus

    Aaboe, K., Knop, Filip Krag, Vilsbøll, Tina, Deacon, Carolyn F., Holst, Jens Juul, Madsbad, Sten & Krarup, T., 2010, In: Diabetes, Obesity and Metabolism. 12, 4, p. 323-333 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone

    Vilsbøll, Tina, Vora, J., Jarlov, H., Kvist, K. & Blonde, L., 2016, In: Clinical Drug Investigation. 36, 4, p. 293-303 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes

    Ørskov, C., Hjorth, S. A., Jensen, A. & Vilsbøll, Tina, 15 Jul 2004, In: Regulatory Peptides. 119, 3, p. 151-4 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 33056950